Solid overall performance under our branded producer agreements also was a positive driver. Related StoriesCareFusion announces services to help improve medication safetyCareFusion third quarter revenue increases 9 percent to $919 millionNatus acquires CareFusion's Nicolet neurodiagnostic businessFor the entire year, revenue for the Pharmaceutical Segment increased 4 % to $93.7 billion, and segment revenue increased 26 % to $1.3 billion. Medical Segment Fourth-quarter income for the Medical Segment improved 7 % to $2. Segment revenue reduced 24 % to $78 million, primarily powered by the negative effect of commodity price raises, certain inventory-related costs and investments made to enhance business IT systems, which were partially offset by the influence of increased quantity to existing clients and net home based business.The proportion of infections caused by MRSA in a variety of cities ranged from 15 to 74 %. Further investigations by the Centers for Disease Control and Prevention, revealed that of the MRSA samples, one genetic type accounted for 97 % of the samples. Dr. Moran says that one genetic type of MRSA is appearing in metropolitan areas across the country, and more analysis should determine how prevalent it is in other areas of the nation.